Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

MRI head brain scan - DedMityay - stock.adobe.com
Semaglutide, Tirzepatide Cut Dementia, Stroke Risk in Type 2 Diabetes

July 18th 2025

Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.

Doctor examines eye anatomy model using magnifying glass | Image credit: Viktor - stock.adobe.com
Clinical Data Predicts Risk of Progression to Proliferative Diabetic Retinopathy

July 15th 2025

Semaglutide. | Image Credit: K KStock - stock.adobe.com
Semaglutide Linked to Lower Dementia Risk in Type 2 Diabetes

June 24th 2025

Type 2 diabetes - greenapple78 - stock.adobe.com
Previsit Tools Boost Diabetes Deprescribing in Older Adults, Study Finds

June 23rd 2025

Diabetic man | Image credit: Krakenimages.com - stock.adobecom
Addressing Barriers to Hispanic Men's Engagement in Diabetes Prevention

June 18th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

AJMC Peer Exchange geometric background
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo